Page last updated: 2024-10-27

flufenamic acid and Hemophilia A

flufenamic acid has been researched along with Hemophilia A in 2 studies

Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.

Hemophilia A: The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Von Kaulla, E2
Von Kaulla, KN2

Other Studies

2 other studies available for flufenamic acid and Hemophilia A

ArticleYear
Factor 8 activity in haemophkilic plasma unmasked by synthetic organic anions.
    Nature: New biology, 1972, Nov-29, Volume: 240, Issue:100

    Topics: Blood Coagulation; Carboxylic Acids; Cinnamates; Factor VIII; Fibrinolytic Agents; Flufenamic Acid;

1972
[Increase of factor VIII-(antihemophilic globulin)-activity in plasma of hemophiliacs following addition of synthetic fibrinolytic compounds].
    Klinische Wochenschrift, 1973, Jul-15, Volume: 51, Issue:14

    Topics: Anions; Carbon Dioxide; Factor VIII; Fibrinolysis; Fibrinolytic Agents; Flufenamic Acid; Hemophilia

1973